Insider Trading activities of Aprea Therapeutics, Inc. (APRE)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aprea Therapeutics, Inc. (APRE) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aprea Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Aprea Therapeutics, Inc. since 2005. The reporting company's ticker symbol is APRE. The reporting company's CIK number is 1781983.
The total value of stock buying since 2005 is $29,388,495.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $18,477.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aprea Therapeutics, Inc. (APRE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-10 1,959,233 $29,388,495 0 $0 263,970 $18,477

Table 2. Detailed insider stock purchases, sales, and option exercises of Aprea Therapeutics, Inc. insiders (APRE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-10-07 Healthcap Vii Gp S.a. (10% Owner) Buy 266,667 15.00 4,000,005
2019-10-07 Attar Eyal C. (SVP, Chief Medical Officer) Buy 400 15.00 6,000
2019-10-07 Seizinger Bernd R. Option Ex 263,970 .07 18,477
2019-10-07 Korbel Gregory Alan (VP of Business Dev't) Buy 500 15.00 7,500
2019-10-07 Versant Vantage I Gp-gp, Llc Buy 333,333 15.00 4,999,995
2019-10-07 Parmar Kush (10% Owner) Buy 333,333 15.00 4,999,995
2019-10-07 Green Jeremy Buy 400,000 15.00 6,000,000
2019-10-07 Coiante Scott M (SVP, Chief Financial Officer) Buy 2,500 15.00 37,500
2019-10-07 Versant Venture Capital V, L.p. Buy 333,333 15.00 4,999,995
2019-10-07 Christenson Johan Buy 266,667 15.00 4,000,005
2019-10-07 Magni Guido Buy 6,500 15.00 97,500
2019-10-07 Schade Christian S (President & CEO) Buy 11,000 15.00 165,000
2019-10-07 Henneman John B Iii Buy 5,000 15.00 75,000

Insider trading activities including stock purchases, stock sales, and option exercises of APRE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aprea Therapeutics, Inc. (symbol APRE, CIK number 1781983) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month